# Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy

> **NCT00887653** · PHASE3 · COMPLETED · sponsor: **The Miriam Hospital** · enrollment: 20 (actual)

## Conditions studied

- HIV
- Hyperlipidemia
- Hypertriglyceridemia
- HIV Infections

## Interventions

- **DRUG:** raltegravir

## Key facts

- **NCT ID:** NCT00887653
- **Lead sponsor:** The Miriam Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-06
- **Final completion:** 2014-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-10-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00887653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00887653, "Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00887653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*